[Clinical manifestations of SARS-CoV-2 infection in children in the middle of pandemic season in a pediatric tertiary center. Report of local COVID Clinical Committee, Hospital de Niños Roberto del Río, Santiago Chile].

Espectro clínico de la infección en niños por virus SARS-CoV-2 en un centro de referencia pediátrico en plena pandemia. Reporte del Comité Clínico COVID, Hospital de Niños Roberto del Río, Santiago Chile.

Journal

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia
ISSN: 0717-6341
Titre abrégé: Rev Chilena Infectol
Pays: Chile
ID NLM: 9305754

Informations de publication

Date de publication:
12 2020
Historique:
received: 23 07 2020
accepted: 20 12 2020
entrez: 12 4 2021
pubmed: 13 4 2021
medline: 16 4 2021
Statut: ppublish

Résumé

SARS-CoV-2 virus infection responsible for de pandemic in course, is a new clinical and physiopathological entity, whose control is still uncertain till we can provide an effective and universal vaccine. In the beginning it was described as a respiratory disease which affects mainly adults, children can have the disease too and in this group the disease can be different than the adult disease. Acute infection in children is mostly mild and when it requires hospital assistance it resolves with support therapy and without complications most of the time. However, in the Pediatric Inflammatory Multisystemic Syndrome is vital the early clinical suspect and refers to a tertiary center to bring support and properly treatment. To describe the clinical spectrum of SARS-CoV-2 virus disease in a pediatric referral center with the pandemic still in development. A case series of 537 patients with SARS-CoV-2 infection treated between March 1 and July 15, 2020 is presented with a description of those who were hospitalized. 127 (23%) of them were hospitalized and of these 69% were symptomatic. Twenty-six patients (20%) of those hospitalized presented PIMS, only one died for complications of his chronic diseases.

Sections du résumé

BACKGROUND
SARS-CoV-2 virus infection responsible for de pandemic in course, is a new clinical and physiopathological entity, whose control is still uncertain till we can provide an effective and universal vaccine. In the beginning it was described as a respiratory disease which affects mainly adults, children can have the disease too and in this group the disease can be different than the adult disease. Acute infection in children is mostly mild and when it requires hospital assistance it resolves with support therapy and without complications most of the time. However, in the Pediatric Inflammatory Multisystemic Syndrome is vital the early clinical suspect and refers to a tertiary center to bring support and properly treatment.
AIM
To describe the clinical spectrum of SARS-CoV-2 virus disease in a pediatric referral center with the pandemic still in development.
METHOD
A case series of 537 patients with SARS-CoV-2 infection treated between March 1 and July 15, 2020 is presented with a description of those who were hospitalized.
RESULTS
127 (23%) of them were hospitalized and of these 69% were symptomatic. Twenty-six patients (20%) of those hospitalized presented PIMS, only one died for complications of his chronic diseases.

Identifiants

pubmed: 33844817
pii: S0716-10182020000600756
doi: 10.4067/S0716-10182020000600756
pii:
doi:

Types de publication

Journal Article

Langues

spa

Sous-ensembles de citation

IM

Pagination

756-761

Auteurs

Fernanda Cofré (F)

Hospital de Niños Roberto del Río, Santiago, Chile.

Jorge Mackenney (J)

Hospital de Niños Roberto del Río, Santiago, Chile.

Cecilia Poli (C)

Hospital de Niños Roberto del Río, Santiago, Chile.

Maryel Riquelme (M)

Hospital de Niños Roberto del Río, Santiago, Chile.

Cristian Carvajal (C)

Hospital de Niños Roberto del Río, Santiago, Chile.

Patricia Álvarez (P)

Hospital de Niños Roberto del Río, Santiago, Chile.

Valeria Acevedo (V)

Hospital de Niños Roberto del Río, Santiago, Chile.

M Lidia Valenzuela (ML)

Hospital de Niños Roberto del Río, Santiago, Chile.

Patricia Verdugo (P)

Hospital de Niños Roberto del Río, Santiago, Chile.

Mónica Varas (M)

Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Lorena Tapia (L)

Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH